Longitudinal Geriatric Assessment to Optimize Outcomes of Older Patients With Muscle-Invasive Bladder Cancer After Radical Cystectomy

Inclusion Criteria: * Ability of participant OR Legally Authorized Representative (LAR) to understand this study, and participant or LAR willingness to sign a written informed consent * Males and females age ≥ 65 years * Diagnosis/disease status * Histologically proven muscle-invasive bladder cancer (MIBC) without metastatic disease. * Patients planning to undergo neoadjuvant chemotherapy and radical cystectomy for MIBC. * Treatment with investigational systemic therapy is permitted if participants will be receiving chemotherapy as part of their treatment plan Exclusion Criteria: * Diagnosed with a psychiatric illness or is in a social situation that would limit compliance with study requirements * Any other known invasive malignancy within previous 2 years with the following EXCEPT: low grade prostate cancer on active surveillance, chronic lymphocytic leukemia CLL on surveillance / observation, non-melanoma skin cancers